{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:53:23Z","timestamp":1778741603658,"version":"3.51.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20691-6","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:44:44Z","timestamp":1761039884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integration of single-cell and bulk RNA sequencing data to identify liquid\u2013liquid phase separation-related prognostic biomarkers in hepatocellular carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanjun","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"3","key":"20691_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"10127","key":"20691_CR2","first-page":"1301","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner, A., Reig, M. & Bruix, J. Hepatocellular Carcinoma Lancet, 391(10127): 1301\u20131314. (2018).","journal-title":"Hepatocellular Carcinoma Lancet"},{"issue":"2","key":"20691_CR3","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel, C. et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8 (2), e180\u2013e190 (2020).","journal-title":"Lancet Glob Health"},{"key":"20691_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay, H. et al. Global, regional and National burden of primary liver cancer by subtype. Eur. J. Cancer. 161, 108\u2013118 (2022).","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"20691_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal, A. G., Kanwal, F. & Llovet, J. M. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat. Rev. Clin. Oncol. 20 (12), 864\u2013884 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"20691_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16 (10), 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10360","key":"20691_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A. et al. Hepatocellular carcinoma. Lancet 400 (10360), 1345\u20131362 (2022).","journal-title":"Lancet"},{"issue":"13","key":"20691_CR8","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3748\/wjg.v27.i13.1330","volume":"27","author":"KL Chen","year":"2021","unstructured":"Chen, K. L. & Gao, J. Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization. World J. Gastroenterol. 27 (13), 1330\u20131340 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"20691_CR9","doi-asserted-by":"publisher","first-page":"e1774","DOI":"10.1002\/onco.13893","volume":"26","author":"PD Chen","year":"2021","unstructured":"Chen, P. D. et al. Long-Term survival of combined Hepatocellular-Cholangiocarcinoma: A nationwide study. Oncologist 26 (10), e1774\u2013e1785 (2021).","journal-title":"Oncologist"},{"key":"20691_CR10","doi-asserted-by":"crossref","unstructured":"Shin, Y. & Brangwynne, C. P. Liquid phase condensation cell. Physiol. Dis. Sci. 357 (6357) (2017).","DOI":"10.1126\/science.aaf4382"},{"issue":"5","key":"20691_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrm.2017.7","volume":"18","author":"SF Banani","year":"2017","unstructured":"Banani, S. F. et al. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell. Biol. 18 (5), 285\u2013298 (2017).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"20691_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41392-022-01076-x","volume":"7","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Liquid-liquid phase separation in tumor biology. Signal. Transduct. Target. Ther. 7 (1), 221 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"20691_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41568-022-00444-7","volume":"22","author":"S Mehta","year":"2022","unstructured":"Mehta, S. & Zhang, J. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat. Rev. Cancer. 22 (4), 239\u2013252 (2022).","journal-title":"Nat. Rev. Cancer"},{"issue":"31","key":"20691_CR14","doi-asserted-by":"publisher","first-page":"e2202855","DOI":"10.1002\/advs.202202855","volume":"9","author":"J Ren","year":"2022","unstructured":"Ren, J. et al. Emerging implications of phase separation in cancer. Adv. Sci. (Weinh). 9 (31), e2202855 (2022).","journal-title":"Adv. Sci. (Weinh)"},{"key":"20691_CR15","doi-asserted-by":"publisher","first-page":"1162211","DOI":"10.3389\/fimmu.2023.1162211","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. Front. Immunol. 14, 1162211 (2023).","journal-title":"Front. Immunol."},{"key":"20691_CR16","doi-asserted-by":"crossref","unstructured":"Igelmann, S., Lessard, F. & Ferbeyre, G. Liquid-liquid phase separation in cancer signaling, metabolism and anticancer therapy. Cancers (Basel) 14 (7) (2022).","DOI":"10.3390\/cancers14071830"},{"issue":"1","key":"20691_CR17","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat. Commun. 13 (1), 4594 (2022).","journal-title":"Nat. Commun."},{"issue":"5","key":"20691_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A. et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36 (5), 411\u2013420. https:\/\/doi.org\/10.1038\/nbt.4096.  PMID: 29608179; PMCID: PMC6700744   (2018).","journal-title":"Nat. Biotechnol."},{"key":"20691_CR19","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning. Brief. Bioinform. 25 (1), bbad487.   https:\/\/doi.org\/10.1093\/bib\/bbad487. PMID: 38197309; PMCID: PMC10777172  (2023).","DOI":"10.1093\/bib\/bbad487"},{"issue":"1","key":"20691_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using cellchat. Nat. Commun. 12 (1), 1088 (2021).","journal-title":"Nat. Commun."},{"issue":"3","key":"20691_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with census. Nat. Methods. 14 (3), 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"issue":"7","key":"20691_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"20691_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16 (5), 284\u2013287 (2012).","journal-title":"Omics"},{"issue":"1","key":"20691_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"20691_CR25","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"20691_CR26","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"20691_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen, S. & Bohlin, J. Statistical predictions with Glmnet. Clin. Epigenetics. 11 (1), 123 (2019).","journal-title":"Clin. Epigenetics"},{"key":"20691_CR28","doi-asserted-by":"publisher","first-page":"820154","DOI":"10.3389\/fgene.2021.820154","volume":"12","author":"M He","year":"2021","unstructured":"He, M. et al. A new prognostic risk score: based on the analysis of Autophagy-Related genes and renal cell carcinoma. Front. Genet. 12, 820154 (2021).","journal-title":"Front. Genet."},{"key":"20691_CR29","doi-asserted-by":"crossref","unstructured":"Kassambara, A. et al. survminer: Drawing Survival Curves using\u2019ggplot2\u2019 (2016).","DOI":"10.32614\/CRAN.package.survminer"},{"key":"20691_CR30","unstructured":"Blanche, P. & Blanche, M. P. Package \u2018timeROC\u2019. https:\/\/cran.r-project.org\/web\/packages\/timeROC (2019)."},{"issue":"4","key":"20691_CR31","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P. et al. Nomograms in oncology: more than Meets the eye. Lancet Oncol. 16 (4), e173\u2013e180 (2015).","journal-title":"Lancet Oncol."},{"key":"20691_CR32","unstructured":"Therneau, T. J. R. A Package for Survival Analysis in S., vol. 2, 2014 (2015)."},{"issue":"24","key":"20691_CR33","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.7150\/jca.35785","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms. J. Cancer. 10 (24), 5944\u20135954 (2019).","journal-title":"J. Cancer"},{"key":"20691_CR34","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. J. B. GSVA: Gene Set Variation Analysis for Microarray and RNA-seq Data, vol. 14, 1\u201315 (2013).","DOI":"10.1186\/1471-2105-14-7"},{"issue":"11","key":"20691_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A. et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28 (11), 1747\u20131756 (2018).","journal-title":"Genome Res."},{"issue":"D1","key":"20691_CR36","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49 (D1), D1144\u2013D1151 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"20691_CR37","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. PubChem bioassay: 2017 update. Nucleic Acids Res. 45 (D1), D955\u2013D963 (2017).","journal-title":"Nucleic Acids Res."},{"key":"20691_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","volume":"1607","author":"SK Burley","year":"2017","unstructured":"Burley, S. K. et al. Protein data bank (PDB): the single global macromolecular structure archive. Methods Mol. Biol. 1607, 627\u2013641 (2017).","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"20691_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13062-020-00267-2","volume":"15","author":"MS Vald\u00e9s-Tresanco","year":"2020","unstructured":"Vald\u00e9s-Tresanco, M. S. et al. AMDock: a versatile graphical tool for assisting molecular Docking with Autodock Vina and Autodock4. Biol. Direct. 15 (1), 12 (2020).","journal-title":"Biol. Direct"},{"issue":"5","key":"20691_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger, D. & de Groot, B. L. Ligand Docking and binding site analysis with PyMOL and Autodock\/Vina. J. Comput. Aided Mol. Des. 24 (5), 417\u2013422 (2010).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"W1","key":"20691_CR41","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res. 46 (W1), W60\u2013w64 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"20691_CR42","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26 (7), 976\u2013978 (2010).","journal-title":"Bioinformatics"},{"issue":"1","key":"20691_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12 (1), 31\u201346 (2022).","journal-title":"Cancer Discov"},{"issue":"4","key":"20691_CR44","doi-asserted-by":"publisher","first-page":"2001961","DOI":"10.1002\/advs.202001961","volume":"8","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. RNF219\/\u03b1-Catenin\/LGALS3 axis promotes hepatocellular carcinoma bone metastasis and associated skeletal complications. Adv. Sci. (Weinh). 8 (4), 2001961 (2021).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"9","key":"20691_CR45","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1111\/cas.14551","volume":"111","author":"RS Nozawa","year":"2020","unstructured":"Nozawa, R. S. et al. Nuclear microenvironment in cancer: control through liquid-liquid phase separation. Cancer Sci. 111 (9), 3155\u20133163 (2020).","journal-title":"Cancer Sci."},{"issue":"3","key":"20691_CR46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41577-021-00572-5","volume":"22","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q., McAtee, C. K. & Su, X. Phase separation in immune signalling. Nat. Rev. Immunol. 22 (3), 188\u2013199 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"20691_CR47","doi-asserted-by":"publisher","first-page":"e2103817","DOI":"10.1002\/advs.202103817","volume":"9","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. circVAMP3 drives CAPRIN1 phase separation and inhibits hepatocellular carcinoma by suppressing c-Myc translation. Adv. Sci. (Weinh). 9 (8), e2103817 (2022).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"22","key":"20691_CR48","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.3c01199","volume":"17","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Long noncoding RNA URB1-Antisense RNA 1 (AS1) suppresses Sorafenib-Induced ferroptosis in hepatocellular carcinoma by driving ferritin phase separation. ACS Nano. 17 (22), 22240\u201322258 (2023).","journal-title":"ACS Nano"},{"issue":"30","key":"20691_CR49","doi-asserted-by":"publisher","first-page":"e2220296120","DOI":"10.1073\/pnas.2220296120","volume":"120","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. Proc. Natl. Acad. Sci. U S A. 120 (30), e2220296120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"20691_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-024-06869-2","volume":"15","author":"ZJ He","year":"2024","unstructured":"He, Z. J. et al. Phase separation of RNF214 promotes the progression of hepatocellular carcinoma. Cell. Death Dis. 15 (7), 483 (2024).","journal-title":"Cell. Death Dis."},{"issue":"11","key":"20691_CR51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41556-023-01270-1","volume":"25","author":"L Sha","year":"2023","unstructured":"Sha, L. et al. Non-canonical MLL1 activity regulates centromeric phase separation and genome stability. Nat. Cell. Biol. 25 (11), 1637\u20131649 (2023).","journal-title":"Nat. Cell. Biol."},{"issue":"11","key":"20691_CR52","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.7150\/jca.94360","volume":"15","author":"R Wan","year":"2024","unstructured":"Wan, R. et al. Decoding gastric cancer: machine learning insights into the significance of COMMDs family in immunotherapy and diagnosis. J. Cancer. 15 (11), 3580\u20133595 (2024).","journal-title":"J. Cancer"},{"issue":"1","key":"20691_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7150\/jca.89338","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Interplay of sphingolipid metabolism in predicting prognosis of GBM patients: towards precision immunotherapy. J. Cancer. 15 (1), 275\u2013292 (2024).","journal-title":"J. Cancer"},{"issue":"1","key":"20691_CR54","doi-asserted-by":"publisher","first-page":"e3580","DOI":"10.1002\/jgm.3580","volume":"26","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Multi-omics analysis reveals that ferroptosis-related gene CISD2 is a prognostic biomarker of head and neck squamous cell carcinoma. J. Gene Med. 26 (1), e3580 (2024).","journal-title":"J. Gene Med."},{"key":"20691_CR55","doi-asserted-by":"publisher","first-page":"1236435","DOI":"10.3389\/fonc.2023.1236435","volume":"13","author":"B Ye","year":"2023","unstructured":"Ye, B. et al. Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma. Front. Oncol. 13, 1236435 (2023).","journal-title":"Front. Oncol."},{"key":"20691_CR56","doi-asserted-by":"publisher","first-page":"107126","DOI":"10.1016\/j.oraloncology.2024.107126","volume":"160","author":"SH Pracha","year":"2025","unstructured":"Pracha, S. H. et al. Targeting macrophage migration inhibitory factor to inhibit T cell immunosuppression in the tumor microenvironment and improve cancer outcomes in head and neck squamous cell carcinoma. Oral Oncol. 160, 107126 (2025).","journal-title":"Oral Oncol."},{"issue":"729","key":"20691_CR57","doi-asserted-by":"publisher","first-page":"eadh8335","DOI":"10.1126\/scitranslmed.adh8335","volume":"16","author":"V Garcia-Flores","year":"2024","unstructured":"Garcia-Flores, V. et al. Deciphering maternal-fetal cross-talk in the human placenta during parturition using single-cell RNA sequencing. Sci. Transl Med. 16 (729), eadh8335 (2024).","journal-title":"Sci. Transl Med."},{"issue":"3","key":"20691_CR58","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5114\/ceh.2023.130499","volume":"9","author":"W Abdelhamed","year":"2023","unstructured":"Abdelhamed, W. et al. The role of serum visfatin and Vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis. Clin. Exp. Hepatol. 9 (3), 210\u2013220 (2023).","journal-title":"Clin. Exp. Hepatol."},{"key":"20691_CR59","doi-asserted-by":"crossref","unstructured":"Yan, P. et al. Midkine as a driver of age-related changes and increase in mammary tumorigenesis. Cancer Cell. 42 (11), 1936\u20131954 (2024).","DOI":"10.1016\/j.ccell.2024.09.002"},{"issue":"3","key":"20691_CR60","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan, V. The role of the complement system in cancer. J. Clin. Invest. 127 (3), 780\u2013789 (2017).","journal-title":"J. Clin. Invest."},{"issue":"34","key":"20691_CR61","doi-asserted-by":"publisher","first-page":"11977","DOI":"10.3748\/wjg.v20.i34.11977","volume":"20","author":"S Sedda","year":"2014","unstructured":"Sedda, S. et al. Proteinase activated-receptors-associated signaling in the control of gastric cancer. World J. Gastroenterol. 20 (34), 11977\u201311984 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"20691_CR62","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi, M. et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal. Transduct. Target. Ther. 9 (1), 176 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"20691_CR63","doi-asserted-by":"publisher","first-page":"p1844352","DOI":"10.1155\/2022\/1844352","volume":"2022","author":"Y Bai","year":"2022","unstructured":"Bai, Y. et al. The role of ANGPTL gene family members in hepatocellular carcinoma. Dis. Markers. 2022, p1844352 (2022).","journal-title":"Dis. Markers"},{"issue":"12","key":"20691_CR64","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s43018-024-00841-x","volume":"5","author":"T Mizutani","year":"2024","unstructured":"Mizutani, T. et al. Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoids. Nat. Cancer. 5 (12), 1852\u20131867 (2024).","journal-title":"Nat. Cancer"},{"key":"20691_CR65","doi-asserted-by":"publisher","first-page":"117585","DOI":"10.1016\/j.biopha.2024.117585","volume":"180","author":"P Lorenc","year":"2024","unstructured":"Lorenc, P. et al. Physiological and tumor-associated angiogenesis: key factors and therapy targeting VEGF\/VEGFR pathway. Biomed. Pharmacother. 180, 117585 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"20691_CR66","doi-asserted-by":"publisher","first-page":"11826","DOI":"10.1038\/s41598-025-96310-1","volume":"15","author":"H Li","year":"2025","unstructured":"Li, H. et al. CALCR interaction with ANTXR1 drives gastric tumor growth and metastasis via AKT signaling pathway. Sci. Rep. 15 (1), 11826 (2025).","journal-title":"Sci. Rep."},{"key":"20691_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2022.11.025","volume":"353","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment. J. Control Release. 353, 63\u201376 (2023).","journal-title":"J. Control Release"},{"key":"20691_CR68","doi-asserted-by":"publisher","first-page":"1551322","DOI":"10.3389\/fimmu.2025.1551322","volume":"16","author":"Z Cai","year":"2025","unstructured":"Cai, Z. et al. IFN-\u03b3-mediated suppression of ANGPT2-Tie2 in endothelial cells facilitates tumor vascular normalization during immunotherapy. Front. Immunol. 16, 1551322 (2025).","journal-title":"Front. Immunol."},{"issue":"1","key":"20691_CR69","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1038\/s41598-025-89217-4","volume":"15","author":"XP Fan","year":"2025","unstructured":"Fan, X. P. et al. Mechanistic insights into PROS1 Inhibition of bladder cancer progression and angiogenesis via the AKT\/GSK3\u03b2\/\u03b2-catenin pathway. Sci. Rep. 15 (1), 4748 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"20691_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41420-022-00972-z","volume":"8","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2\/caspase-3 pathway. Cell. Death Discov. 8 (1), 162 (2022).","journal-title":"Cell. Death Discov"},{"issue":"1","key":"20691_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund, S., Avanzato, D. & Lanzetti, L. Emerging functions of the EGFR in cancer. Mol. Oncol. 12 (1), 3\u201320 (2018).","journal-title":"Mol. Oncol."},{"key":"20691_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","volume":"85","author":"E Levantini","year":"2022","unstructured":"Levantini, E. et al. EGFR signaling pathway as therapeutic target in human cancers. Semin Cancer Biol. 85, 253\u2013275 (2022).","journal-title":"Semin Cancer Biol."},{"issue":"12","key":"20691_CR73","doi-asserted-by":"publisher","first-page":"e52711","DOI":"10.1371\/journal.pone.0052711","volume":"7","author":"MU Latasa","year":"2012","unstructured":"Latasa, M. U. et al. Regulation of Amphiregulin gene expression by \u03b2-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system. PLoS One. 7 (12), e52711 (2012).","journal-title":"PLoS One"},{"key":"20691_CR74","doi-asserted-by":"publisher","first-page":"101942","DOI":"10.1016\/j.redox.2021.101942","volume":"41","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation. Redox Biol. 41, 101942 (2021).","journal-title":"Redox Biol."},{"issue":"1","key":"20691_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13046-019-1082-6","volume":"38","author":"Y Yin","year":"2019","unstructured":"Yin, Y. et al. EGFR signaling confers resistance to BET Inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC. J. Exp. Clin. Cancer Res. 38 (1), 83 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"20691_CR76","doi-asserted-by":"crossref","unstructured":"Luo, Y. et al. Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review). Int. J. Oncol. 59 (2) (2021).","DOI":"10.3892\/ijo.2021.5242"},{"issue":"10","key":"20691_CR77","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/art.41753","volume":"73","author":"J Yao","year":"2021","unstructured":"Yao, J. et al. ICBP90 regulates MIF Expression, glucocorticoid Sensitivity, and apoptosis at the MIF immune susceptibility locus. Arthritis Rheumatol. 73 (10), 1931\u20131942 (2021).","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"20691_CR78","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12253-016-0138-6","volume":"23","author":"CC Nobre","year":"2017","unstructured":"Nobre, C. C. et al. Macrophage migration inhibitory factor (MIF): biological activities and relation with cancer. Pathol. Oncol. Res. 23 (2), 235\u2013244 (2017).","journal-title":"Pathol. Oncol. Res."},{"issue":"22","key":"20691_CR79","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1111\/bph.15622","volume":"178","author":"TH Wirtz","year":"2021","unstructured":"Wirtz, T. H. et al. Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma. Br. J. Pharmacol. 178 (22), 4452\u20134467 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"20691_CR80","doi-asserted-by":"crossref","unstructured":"He, Z. et al. Mapping the single-cell landscape of acral melanoma and analysis of the molecular regulatory network of the tumor microenvironments. Elife 11 (2022).","DOI":"10.7554\/eLife.78616"},{"key":"20691_CR81","doi-asserted-by":"publisher","first-page":"1389411","DOI":"10.3389\/fimmu.2024.1389411","volume":"15","author":"T Sakata","year":"2024","unstructured":"Sakata, T. et al. Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma. Front. Immunol. 15, 1389411 (2024).","journal-title":"Front. Immunol."},{"issue":"6","key":"20691_CR82","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent, L. N. & Leone, G. The broken cycle: E2F dysfunction in cancer. Nat. Rev. Cancer. 19 (6), 326\u2013338 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"20691_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcancer.2023.03.004","volume":"92","author":"A Kassab","year":"2023","unstructured":"Kassab, A., Gupta, I. & Moustafa, A. A. Role of E2F transcription factor in oral cancer: recent insight and advancements. Semin Cancer Biol. 92, 28\u201341 (2023).","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"20691_CR84","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.surg.2023.04.030","volume":"174","author":"K Chida","year":"2023","unstructured":"Chida, K. et al. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery 174 (2), 307\u2013314 (2023).","journal-title":"Surgery"},{"issue":"11","key":"20691_CR85","doi-asserted-by":"publisher","first-page":"e0242179","DOI":"10.1371\/journal.pone.0242179","volume":"15","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7. PLoS One. 15 (11), e0242179 (2020).","journal-title":"PLoS One"},{"issue":"10","key":"20691_CR86","doi-asserted-by":"publisher","first-page":"100815","DOI":"10.1016\/j.tranon.2020.100815","volume":"13","author":"JX Xiao","year":"2020","unstructured":"Xiao, J. X. et al. Anillin facilitates cell proliferation and induces tumor growth of hepatocellular carcinoma via miR-138\/SOX4 axis regulation. Transl Oncol. 13 (10), 100815 (2020).","journal-title":"Transl Oncol."},{"issue":"11","key":"20691_CR87","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/mc.23454","volume":"61","author":"F Hao","year":"2022","unstructured":"Hao, F. et al. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1\/SOX4\/Anillin axis via repressing miRNA-383-5p transcription. Mol. Carcinog. 61 (11), 975\u2013988 (2022).","journal-title":"Mol. Carcinog."},{"key":"20691_CR88","doi-asserted-by":"publisher","first-page":"102154","DOI":"10.1016\/j.ctrv.2021.102154","volume":"94","author":"MJ Duffy","year":"2021","unstructured":"Duffy, M. J. et al. MYC as a target for cancer treatment. Cancer Treat. Rev. 94, 102154 (2021).","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"20691_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran, R. et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19 (1), 23\u201336 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"20691_CR90","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","volume":"40","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y. et al. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/\u03b2-catenin\/c-Myc signaling and reprogramming Glycolysis. J. Exp. Clin. Cancer Res. 40 (1), 13 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"20691_CR91","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1158\/0008-5472.CAN-22-0232","volume":"83","author":"R Dhanasekaran","year":"2023","unstructured":"Dhanasekaran, R. et al. MYC overexpression drives immune evasion in hepatocellular carcinoma that is reversible through restoration of Proinflammatory macrophages. Cancer Res. 83 (4), 626\u2013640 (2023).","journal-title":"Cancer Res."},{"issue":"7","key":"20691_CR92","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-021-03973-5","volume":"12","author":"P Xia","year":"2021","unstructured":"Xia, P. et al. MYC-targeted WDR4 promotes proliferation, metastasis, and Sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell. Death Dis. 12 (7), 691 (2021).","journal-title":"Cell. Death Dis."},{"issue":"10","key":"20691_CR93","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/cac2.12600","volume":"44","author":"DH Kim","year":"2024","unstructured":"Kim, D. H. et al. Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-\u03b21 (TGF-\u03b21) availability and inhibits hepatocarcinogenesis. Cancer Commun. (Lond). 44 (10), 1106\u20131129 (2024).","journal-title":"Cancer Commun. (Lond)"},{"key":"20691_CR94","doi-asserted-by":"crossref","unstructured":"Cao, F., Luo, A. & Yang, C. G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase. Cell Signal 87, 110098 (2021).","DOI":"10.1016\/j.cellsig.2021.110098"},{"key":"20691_CR95","doi-asserted-by":"crossref","unstructured":"Yang, H. C. et al. The redox role of G6PD in cell growth, cell death, and cancer. Cells 8 (9) (2019).","DOI":"10.3390\/cells8091055"},{"issue":"3","key":"20691_CR96","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bj.2020.08.001","volume":"44","author":"HC Yang","year":"2021","unstructured":"Yang, H. C., Stern, A. & Chiu, D. T. G6PD: A hub for metabolic reprogramming and redox signaling in cancer. Biomed. J. 44 (3), 285\u2013292 (2021).","journal-title":"Biomed. J."},{"issue":"4","key":"20691_CR97","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/abbs\/gmy009","volume":"50","author":"M Lu","year":"2018","unstructured":"Lu, M. et al. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition. Acta Biochim. Biophys. Sin (Shanghai). 50 (4), 370\u2013380 (2018).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"issue":"4","key":"20691_CR98","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1055-9965.EPI-18-0638","volume":"28","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. LGALS3 promotes treatment resistance in glioblastoma and is associated with tumor risk and prognosis. Cancer Epidemiol. Biomarkers Prev. 28 (4), 760\u2013769 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"20691_CR99","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5483\/BMBRep.2020.53.4.020","volume":"53","author":"SJ Kim","year":"2020","unstructured":"Kim, S. J. & Chun, K. H. Non-classical role of Galectin-3 in cancer progression: translocation to nucleus by carbohydrate-recognition independent manner. BMB Rep. 53 (4), 173\u2013180 (2020).","journal-title":"BMB Rep."},{"issue":"10","key":"20691_CR100","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/labinvest.2015.77","volume":"95","author":"N Serizawa","year":"2015","unstructured":"Serizawa, N. et al. Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation. Lab. Invest. 95 (10), 1145\u20131156 (2015).","journal-title":"Lab. Invest."},{"issue":"4","key":"20691_CR101","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.livres.2020.11.001","volume":"4","author":"T Setayesh","year":"2020","unstructured":"Setayesh, T., Colquhoun, S. D. & Wan, Y. Y. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Liver Res. 4 (4), 173\u2013179 (2020).","journal-title":"Liver Res."},{"issue":"1","key":"20691_CR102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12935-024-03309-1","volume":"24","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. High LGALS3 expression induced by HCP5\/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. Cancer Cell. Int. 24 (1), 142 (2024).","journal-title":"Cancer Cell. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20691-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:04:35Z","timestamp":1761044675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20691-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20691"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20691-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36805"}}